Vericel Corp (VCEL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Vericel Corp (VCEL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7216
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vericel Corp (Vericel) develops and markets advanced cell therapies for sports medicine and severe burn domains. Its major products include MACI (autologous cultured chondrocytes on porcine collagen membrane) for the treatment of cartilage defects; and Epicel cultured epidermal autografts for skin replacement. The company is also developing ixmyelocel-T technology, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM). It has manufacturing facilities in Cambridge, Massachusetts; Ann Harbour, Michigan and Kastrup, Denmark. The company sells its products through cell therapy specialists. Vericel is headquartered in Cambridge, the US.

Vericel Corp (VCEL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vericel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vericel Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Vericel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vericel Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Vericel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Vericel Corp, Medical Equipment, Deal Details 10
Innovative Cellular Therapeutics Enters into Licensing Agreement with Vericel 10
Equity Offering 11
Vericel Plans to Raise up to USD200 Million in Public Offering of Securities 11
Vericel Raises USD74.8 Million in Public Offering of Shares 12
Vericel Raises USD19.6 Million in Public Offering of Shares 14
Aastrom Biosciences Raises USD15 Million in Private Placement of Shares 15
Aastrom Biosciences Raises USD40 Million in Public Offering of Shares 16
Aastrom Biosciences Completes Public Offering Of Shares For US$9 Million 18
Vericel Corp – Key Competitors 19
Vericel Corp – Key Employees 20
Vericel Corp – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 06, 2018: Vericel Reports Record Second Quarter Revenues of $19.0 Million and Raises Full Year 2018 Revenue Guidance 22
May 08, 2018: Vericel Reports First Quarter 2018 Financial Results 24
Mar 05, 2018: Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance 26
Nov 07, 2017: Vericel Reports Third-Quarter 2017 Financial Results 28
Aug 09, 2017: Vericel Reports Second-Quarter 2017 Financial Results 29
May 10, 2017: Vericel Reports First-Quarter 2017 Financial Results 31
Mar 10, 2017: Vericel Reports Fourth-Quarter and Year-End 2016 Financial Results 33
Corporate Communications 35
Aug 20, 2018: Vericel names Jonathan Hopper as chief medical officer 35
Apr 10, 2017: Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Vericel Corp, Medical Equipment, Key Facts, 2017 2
Vericel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Vericel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vericel Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Vericel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vericel Corp, Deals By Market, 2012 to YTD 2018 8
Vericel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Innovative Cellular Therapeutics Enters into Licensing Agreement with Vericel 10
Vericel Plans to Raise up to USD200 Million in Public Offering of Securities 11
Vericel Raises USD74.8 Million in Public Offering of Shares 12
Vericel Raises USD19.6 Million in Public Offering of Shares 14
Aastrom Biosciences Raises USD15 Million in Private Placement of Shares 15
Aastrom Biosciences Raises USD40 Million in Public Offering of Shares 16
Aastrom Biosciences Completes Public Offering Of Shares For US$9 Million 18
Vericel Corp, Key Competitors 19
Vericel Corp, Key Employees 20
Vericel Corp, Other Locations 21
Vericel Corp, Subsidiaries 21

List of Figures
Vericel Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Vericel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Vericel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Vericel Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Vericel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Vericel Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Vericel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Vericel Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Vericel Corp (VCEL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medical Facilities Corp (DR):企業の財務・戦略的SWOT分析
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • Actelion Ltd:戦略・SWOT・企業財務分析
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • McKesson Corp (MCK):医療機器:M&Aディール及び事業提携情報
    Summary McKesson Corp (McKesson) is a provider of healthcare services and information technology solutions. It distributes pharmaceuticals, medical equipment, and health and beauty care products in North America and overseas. The company also develops and provides decision support software and syste …
  • Worthington Industries Inc:戦略・SWOT・企業財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Eli Lilly and Co (LLY):医療機器:M&Aディール及び事業提携情報
    Summary Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, immune disorders, men's health and musculoskeletal problems. It als …
  • TD Ameritrade Holding Corp:企業の戦略・SWOT・財務分析
    TD Ameritrade Holding Corp - Strategy, SWOT and Corporate Finance Report Summary TD Ameritrade Holding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Continental Engineering Corporation:企業の戦略・SWOT・財務分析
    Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report Summary Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Eaton Corporation plc:戦略・SWOT・企業財務分析
    Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report Summary Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Shenzhen Jinjia Group Co., Ltd.:戦略・SWOT・企業財務分析
    Shenzhen Jinjia Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shenzhen Jinjia Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Simcere Pharmaceutical Group-製薬・医療分野:企業M&A・提携分析
    Summary Simcere Pharmaceutical Group (Simcere) is a drug discovery company that manufactures and supplies branded generic and prescription pharmaceutical products. The company offers products in therapeutic areas including anti-tumor, central nervous, anti-infection, cardiovascular, skeletal muscle, …
  • Tree Top, Inc.:企業の戦略・SWOT・財務情報
    Tree Top, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tree Top, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • LG Household & Health Care Ltd:戦略・SWOT・企業財務分析
    LG Household & Health Care Ltd - Strategy, SWOT and Corporate Finance Report Summary LG Household & Health Care Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ansaldo Energia SpA-エネルギー分野:企業M&A・提携分析
    Summary Ansaldo Energia S.p.A. (Ansaldo Energia), a subsidiary of CDP Equity SpA, is a power generation company and a supplier of power plant equipments and related services. It provides power plant equipments such as gas turbines, steam turbines, turbogenerators, and hydrogenerators used in fossil …
  • Rio Grande Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Rio Grande Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Chemetall GmbH:企業の戦略的SWOT分析
    Chemetall GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Alimera Sciences Inc (ALIM):企業の財務・戦略的SWOT分析
    Alimera Sciences Inc (ALIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cineworld Group Plc:企業の戦略・SWOT・財務分析
    Cineworld Group Plc - Strategy, SWOT and Corporate Finance Report Summary Cineworld Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ingram Micro Inc.:企業の戦略的SWOT分析
    Ingram Micro Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • EKF Diagnostics Holdings Plc (EKF):医療機器:M&Aディール及び事業提携情報
    Summary EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company that designs, develops, manufactures, and commercializes point-of-care (POC) devices and tests and chemical reagents used for manufacturing in central laboratories. Its POC range includes hemoglobin analyzers, glucose …
  • Interpace Biosciences Inc (IDXG):企業の製品パイプライン分析
    Summary Interpace Biosciences Inc (Interpace Biosciences) formerly Interpace Diagnostics Group Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathf …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆